Document Detail


MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium.
MedLine Citation:
PMID:  21447688     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The inflammatory response in age-related macular degeneration (AMD) is characterized by mononuclear leukocyte infiltration of the outer blood-retina barrier formed by the retinal pigment epithelium (RPE). A key mechanistic element in AMD progression is RPE dysfunction and apoptotic cell loss. The purpose of this study was to evaluate whether monocyte chemoattractant protein (MCP)-1-activated monocytes induce human RPE apoptosis and whether Ca(2+) and reactive oxygen species (ROS) are involved in this process.
METHODS: A cell-based fluorometric assay was used to measure intracellular Ca(2+) concentrations ([Ca(2+)](i)) in RPE cells loaded with fluorescent Ca(2+) indicator. Intracellular RPE ROS levels were measured by using the 5- and 6-chloromethyl-2',7'-dichlorodihydrofluorescence diacetate acetyl ester (CM-H(2)DCFDA) assay. RPE apoptosis was evaluated by activated caspase-3, Hoechst staining, and apoptosis ELISA.
RESULTS: MCP-1-activated human monocytes increased [Ca(2+)](i), ROS levels, and apoptosis in RPE cells, all of which were inhibited by 8-bromo-cyclic adenosine diphosphoribosyl ribose (8-Br-cADPR), an antagonist of cADPR. Although the ROS scavengers pyrrolidinedithiocarbamate (PDTC) and N-acetylcysteine (NAC) significantly inhibited ROS production and apoptosis induced by activated monocytes, they did not affect induced Ca(2+) levels. The induced Ca(2+) levels and apoptosis in RPE cells were inhibited by an antibody against cluster of differentiation antigen 14 (CD14), an adhesion molecule expressed by these cells.
CONCLUSIONS: These results indicate that CD14, Ca(2+), and ROS are involved in activated monocyte-induced RPE apoptosis and that cADPR contributes to these changes. Understanding the complex interactions among CD14, cADPR, Ca(2+), and ROS may provide new insights and treatments of retinal diseases, including AMD.
Authors:
Dongli Yang; Susan G Elner; Xun Chen; Matthew G Field; Howard R Petty; Victor M Elner
Related Documents :
15843208 - Modulation of translation factor's gene expression by histone deacetylase inhibitors in...
21501368 - Phagocytosis of melanized aspergillus conidia by macrophages exerts cytoprotective effe...
21151158 - The distinct role of guanine nucleotide exchange factor vav1 in bcl-2 transcription and...
21252908 - F-box protein 10, an nf-κb-dependent anti-apoptotic protein, regulates trail-induced a...
15466378 - Transgenic mice overexpressing bmp4 develop a fibrodysplasia ossificans progressiva (fo...
20859658 - Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory disease...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-07-29
Journal Detail:
Title:  Investigative ophthalmology & visual science     Volume:  52     ISSN:  1552-5783     ISO Abbreviation:  Invest. Ophthalmol. Vis. Sci.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-08-01     Completed Date:  2011-09-30     Revised Date:  2012-01-02    
Medline Journal Info:
Nlm Unique ID:  7703701     Medline TA:  Invest Ophthalmol Vis Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  6026-34     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan 48105-0714, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antibodies / pharmacology
Antigens, CD14 / immunology
Apoptosis / drug effects,  immunology*
Calcium / metabolism
Calcium Signaling / physiology
Cells, Cultured
Chemokine CCL2 / immunology*,  metabolism
Cyclic ADP-Ribose / analogs & derivatives,  antagonists & inhibitors,  pharmacology
Humans
Macular Degeneration / immunology*,  pathology
Middle Aged
Monocytes / immunology*,  pathology
Reactive Oxygen Species / antagonists & inhibitors,  metabolism
Retinal Pigment Epithelium / immunology*,  pathology
Grant Support
ID/Acronym/Agency:
EY019986/EY/NEI NIH HHS; P30EY07003/EY/NEI NIH HHS; R01EY009441/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
0/8-bromo-cyclic-ADP-ribose; 0/Antibodies; 0/Antigens, CD14; 0/CCL2 protein, human; 0/Chemokine CCL2; 0/Reactive Oxygen Species; 119340-53-3/Cyclic ADP-Ribose; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sustained antibiotic release from an intraocular lens-hydrogel assembly for cataract surgery.
Next Document:  Automated perimetry: using gaze-direction data to improve the estimate of scotoma edges.